Osaic Holdings
CRVS icon

Osaic Holdings’s Corvus Pharmaceuticals CRVS Stock Holding History

Osaic Holdings’s Portfolio CRVS Stock Details CRVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.9K Sell
728
-7
-1% -$97 ﹤0.01% 6566
2026
Q1 		$10.8K Sell
735
-67,258
-99% -$1.07M ﹤0.01% 6248
2025
Q4 		$524K Buy
67,993
+1
+0% +$8 ﹤0.01% 3296
2025
Q3 		$390K Buy
67,992
+670
+1% +$3.43K ﹤0.01% 3636
2025
Q2 		$269K Sell
67,322
-667
-1% -$2.43K ﹤0.01% 3682
2025
Q1 		$216K Hold
67,989
– – ﹤0.01% 3556
2024
Q4 		$364K Buy
67,989
+51,255
+306% +$383K ﹤0.01% 3083
2024
Q3 		$88.4K Buy
16,734
+16,200
+3,034% +$58.2K ﹤0.01% 4317
2024
Q2 		$971 Sell
534
-666
-56% -$1.24K ﹤0.01% 6828
2024
Q1 		$2.14K Hold
1,200
– – ﹤0.01% 6445
2023
Q4 		$2.11K Sell
1,200
-1,200
-50% -$1.75K ﹤0.01% 6526
2023
Q3 		$3.5K Buy
2,400
+1,300
+118% +$2.75K ﹤0.01% 6416
2023
Q2 		$2.52K Hold
1,100
– – ﹤0.01% 6580
2023
Q1 		$1K Buy
1,100
+1,000
+1,000% +$780 ﹤0.01% 6954
2022
Q4 		$0 Sell
100
-1,000
-91% -$885 ﹤0.01% 7218
2022
Q3 		$1K Hold
1,100
– – ﹤0.01% 6958
2022
Q2 		$1K Hold
1,100
– – ﹤0.01% 7051
2022
Q1 		$2K Hold
1,100
– – ﹤0.01% 6861
2021
Q4 		$3K Hold
1,100
– – ﹤0.01% 6859
2021
Q3 		$5K Hold
1,100
– – ﹤0.01% 6516
2021
Q2 		$3K Hold
1,100
– – ﹤0.01% 6580
2021
Q1 		$3K Buy
1,100
+100
+10% +$361 ﹤0.01% 6352
2020
Q4 		$4K Hold
1,000
– – ﹤0.01% 5834
2020
Q3 		$4K Hold
1,000
– – ﹤0.01% 5627
2020
Q2 		$3K Hold
1,000
– – ﹤0.01% 5645
2020
Q1 		$2K Buy
+1,000
New +$4.06K ﹤0.01% 5656

Other funds holding CRVS

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ASP
Adams Street Partners Chicago, Illinois $443M AUM 49.46% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Osaic Holdings's CRVS Position: Q2 2026 in Review

Osaic Holdings reduced its Corvus Pharmaceuticals (CRVS) stake by 0.95% in Q2 2026, selling an estimated $97 and leaving 728 shares worth $10.9K. The position accounts for ﹤0.01% of the portfolio, ranked #6566.

Osaic Holdings first reported a position in CRVS in Q1 2020 and has held it in 26 quarters since. The position peaked at $524K in Q4 2025. 174 funds tracked by Wall St. Rank hold CRVS as of Q2 2026.

  • Osaic Holdings held 728 shares of Corvus Pharmaceuticals worth $10.9K as of Q2 2026.
  • Osaic Holdings sold 7 Corvus Pharmaceuticals shares in Q2 2026, an estimated $97.
  • Corvus Pharmaceuticals made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #6566 holding.
  • Osaic Holdings first reported a position in Corvus Pharmaceuticals in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Corvus Pharmaceuticals position peaked at $524K in Q4 2025.
  • 174 funds tracked by Wall St. Rank held Corvus Pharmaceuticals as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.